Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 1701-1715

  Pongrac, Igor M ^a   Pavičić, Ivan ^b   Milić, Mirta ^b   Ahmed, Lada Brkić ^a   Babič, Michal ^c   Horák, Daniel ^c   Vrček, Ivana Vinković ^b   Gajović, Srećko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Biocompatibility; Genotoxicity; Murine neural stem cells; Oxidative stress; Superparamagnetic iron oxide nanoparticles

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ANTIOXIDANT; DEXTRAN; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; EXPOSURE; FEMALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NANOANALYSIS; NEURAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; SURFACE PROPERTY; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HYDRODYNAMICS; MEMBRANE POTENTIAL; METABOLISM; PATHOLOGY; STATIC ELECTRICITY; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; CELL SURVIVAL; DEXTRANS; DNA DAMAGE; FERRIC COMPOUNDS; HYDRODYNAMICS; MAGNETITE NANOPARTICLES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE POTENTIALS; MICE, INBRED C57BL; NANOPARTICLES; NEURAL STEM CELLS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STATIC ELECTRICITY;

EID: 84964414204     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S102730     Document Type: Article

References (73)

1. Srinivas M, Aarntzen EH, Bulte JW, et al. Imaging of cellular therapies. Adv Drug Del Rev. 2010;62:1080–1093.
2. Shubayev VI, Pisanic TR 2nd, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev. 2009;61:467–477.
3. Hoehn M, Wiedermann D, Justicia C, et al. Cell tracking using magnetic resonance imaging. J Physiol. 2007;584:25–30.
4. Küstermann E, Himmelreich U, Kandal K, et al. Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging. 2008;3:27–37.
5. Chen J, Rogers SC, Kavdia M. Analysis of kinetics of dihydroethidium fluorescence with superoxide using xanthine oxidase and hypoxanthine assay. Ann Biomed Eng. 2013;41:327–337.
6. Benetti F, Bregoli L, Olivato I, Sabbioni E. Effects of metal(loid)-based nanomaterials on essential element homeostasis: The central role of nanometallomics for nanotoxicology. Metallomics. 2014;6:729–747.
7. Novotna B, Jendelova P, Kapcalova M, et al. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles. Toxicol Lett. 2012;210:53–63.
8. Singh N, Jenkins GJ, Asadi R, Doak S. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1:5358.
9. Huang DM, Chung TH, Hung Y, et al. Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells. Toxicol Appl Pharmacol. 2008;231:208–215.
10. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–627.
11. Hohnholt MC, Geppert M, Luther EM, Petters C, Bulcke F, Dringen R. Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res. 2013;38:227–239.
12. Hurd TR, Murphy MP. Biological systems relevant for redox signalling and control. In: Jacob C, Winyard PG, editors. Redox Signalling and Regulation in Biology and Medicine. Weinheim, Germany: Wiley; 2009:13–45.
13. Wang L, Nagesha DK, Selvarasah S, Dokmeci MR, Carrier RL. Toxicity of CdSe nanoparticles in Caco-2 cell culture. J Nanobiotechnology. 2008;6:11.
14. Karlsson HL, Gustafsson J, Cronholm P, Möller L. Size-dependent toxicity of metal oxide particles – a comparison between nano- and micrometer size. Toxicol Lett. 2009;188:112–118.
15. Donaldson K, Poland CA, Schins RP. Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies. Nanotoxicology. 2010;4:414–420.
16. Lin WS, Xu Y, Huang CC, et al. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells. J Nanopart Res. 2009;11:25–39.
17. Deng XY, Luan QX, Chen WT, et al. Nanosized zinc oxide particles induce neural stem apoptosis. Nanotechnology. 2009;20:115101.
18. Yang H, Liu C, Yang DF, Zhang HS, Xi ZG. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29:69–78.
19. Könczöl M, Ebeling S, Goldenberg E, et al. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem Res Toxicol. 2011;24:1460−1475.
20. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283:65−87.
21. Harper S, Usenko C, Hutchison JE, Maddux BL, Tanguay RL. In vivo biodistribution and toxicity depends on nanomaterial composition, size, surface functionalisation and route of exposure. J Exp Nanosci. 2008;3:195–206.
22. El-Ansary A, Al-Daihan S. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol. 2009;2009:754810.
23. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–839.
24. Dusinska M, Dusinska M, Fjellsbø L, et al. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine. 2009;4:605–607.
25. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm. 2009;72:370–377.
26. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations – many questions, some answers. Mutat Res. 2009;681:241–258.
27. Nel A, Xia T, Meng H, et al. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res. 2012;46:607–621.
28. Harris G, Palosaari T, Magdolenova Z, et al. Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging. Nanotoxicology. 2015;9 Suppl 1:87–94.
29. George S, Xia T, Rallo R, et al. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano. 2011;5:1805–1817.
30. Horak D, Babic M, Jendelová P, et al. D-mannose-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem. 2007;18:635–644.
31. Allen MJ, MacRenaris KW, Venkatasubramanian PN, Meade TJ. Cellular delivery of MRI contrast agents. Chem Biol. 2004;11:301–307.
32. Zhang Y, Zhang J. Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells. J Colloid Interface Sci. 2005;283:352–357.
33. Babič M, Horák D, Trchová M, et al. Poly(l-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem. 2008;19:740–745.
34. Rueger MA, Muesken S, Walberer M, et al. Effects of minocycline on endogenous neural stem cells after experimental stroke. Neuroscience. 2012;215:174–183.
35. Horák D, Babič M, Jendelová P, et al. Effect of different magnetic nanoparticle coatings on the efficiency of stem cell labeling. J Magn Magn Mater. 2009;321:1539–1547.
36. Vinković Vrček I, Pavičić I, Crnković T, et al. Does surface coating of metallic nanoparticles modulate their interferences with in vitro assays? RSC Adv. 2015;5:70787–70807.
37. Mahmoudi M, Abdelmonem AM, Behzadi S, et al. Temperature: the “ignored” factor at the nanobio interface. ACS Nano. 2013;7:6555–6562.
38. Griffiths SM, Singh N, Jenkins GJ, et al. Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal Chem. 2011;83:3778–3785.
39. Kamencic H, Lyon A, Paterson PG, Juurlink BH. Monochlorobimane fluorometric method to measure tissue glutathione. Anal Biochem. 2000;286:35–37.
40. Chen JC, Zhang X, Singleton TP, Kiechle FL. Mitochondrial membrane potential change induced by Hoechst 33342 in myelogenous leukemia cell line HL-60. Ann Clin Lab Sci. 2004;34:458–466.
41. Fairless R, Beck A, Kravchenko M, et al. Membrane potential measurements of isolated neurons using a voltage-sensitive dye. PLoS One. 2013;8:e58260.
42. Huk A, Collins AR, El Yamani N, et al. Critical factors to be considered when testing nanomaterials for genotoxicity with the comet assay. Mutagenesis. 2015;30:85–88.
43. Collins AR, Dobson VL, Dusinská M, Kennedy G, Stětina R. The comet assay: what can it really tell us? Mutat Res. 1997;375:183–193.
44. Asharani PV, Mun GL, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279–290.
45. Lai ZW, Yan Y, Caruso F, Nice EC. Emerging techniques in proteomics for probing nano-bio interactions. ACS Nano. 2012;6:10438–10448.
46. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999;27:916–921.
47. Xiao GG, Wang M, Li N, Loo JA, Nel AE. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem. 2003;278:50781–50790.
48. Ma P, Luo Q, Chen J, et al. Intraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int J Nanomedicine. 2012;7:4809–4818.
49. Wang J, Sun P, Bao Y, Liu J, An L. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol in Vitro. 2011;25:242–250.
50. Bray RC, Cockle SA, Fielden EM, Roberts PB, Rotilio G, Calabrese L. Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem J. 1974;139:43–48.
51. Lushchak VI. Adaptive response to oxidative stress: bacteria, fungi, plants and animals. Comp Biochem Physiol C Toxicol Pharmacol. 2011;153:175–190.
52. Krohn AJ, Wahlbrink T, Prehn JH. Mitochondrial depolarization is not required for neuronal apoptosis. J Neurosci. 1999;19:7394–7404.
53. Ward MW, Huber HJ, Weisová P, Düssmann H, Nicholls DG, Prehn JH. Mitochondrial and plasma membrane potential of cultured cerebellar neurons during glutamate-induced necrosis, apoptosis, and tolerance. J Neurosci. 2007;27:8238–8249.
54. Sanchez-Alcazar JA, Ault JG, Khodjakov A, Schneider E. Increased mitochondrial cytochrome C levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells. Cell Death Differ. 2000;7:1090–1100.
55. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 2006;1757:509–517.
56. Andón FT, Fadeel B. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc Chem Res. 2013;46:733–742.
57. Forkink M, Manjeri GR, Liemburg-Apers DC, et al. Mitochondrial hyperpolarization during chronic complex I inhibition is sustained by low activity of complex II, III, IV and V. Biochim Biophys Acta. 2014;1837:1247–1256.
58. Poburko D, Santo-Domingo J, Demaurex N. Dynamic regulation of the mitochondrial proton gradient during cytosolic calcium elevations. J Biol Chem. 2011;286:11672–11684.
59. Cao J, Liu Y, Jia L, et al. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic Biol Med. 2007;43:968–975.
60. Gergely P Jr, Niland B, Gonchoroff N, Pullmann R Jr, Phillips PE, Perl A. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J Immunol. 2002;169:1092–1101.
61. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (ΔΨm) in apoptosis. Apoptosis. 2003;8:115–128.
62. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11:621–632.
63. Liang BC, Miller L, Weller A. Ethyl-nitrosourea transformed astrocytes exhibit mitochondrial membrane hyperpolarization and constrained apoptosis. Apoptosis. 1999;4:89–97.
64. Nakaya H, Takeda Y, Tohse N, Kanno M. Mechanism of the membrane depolarization induced by oxidative stress in guinea-pig ventricular cells. J Mol Cell Cardiol. 1992;24:523–534.
65. Stroh A, Tsai HC, Wang LP, et al. Tracking stem cell differentiation in the setting of automated optogenetic stimulation. Stem Cells. 2011;29:78–88.
66. Xavier JM, Morgado AL, Rodrigues CM, Solá S. Tauroursodeoxycholic acid increases neural stem cell pool and neuronal conversion by regulating mitochondria-cell cycle retrograde signaling. Cell Cycle. 2014;13:3576–3589.
67. Olguín-Albuerne M, Morán J. ROS produced by NOX2 control in vitro development of cerebellar granule neurons development. ASN Neuro. 2015;7:1–28.
68. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12:913–922.
69. Bhabra G, Sood A, Fisher B, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol. 2009;4:876–883.
70. Sun C, Carpenter C, Pratx G, Xing L. Facile synthesis of amine-functionalized Eu3+-doped La(OH)3 nanophosphors for bioimaging. Nanoscale Res Lett. 2011;6:24–30.
71. Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P. An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure. Nanotechnology. 2009;20:225104.
72. Berry CC, Charles S, Wells S, Dalby MJ, Curtis AS. The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. Int J Pharm. 2004;269:211–225.
73. Kim JS, Yoon TJ, Yu KN, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci. 2006;89:338–347.